AngioWaveNet vs VX1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AngioWaveNet

by Angiowave Imaging

VX1

by Volta Medical

AI Verdict

AngioWaveNet enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization labs, focusing on imaging quality. In contrast, VX1 assists cardiac electrophysiologists by providing real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. While both are FDA-cleared cardiology AI tools, AngioWaveNet targets imaging enhancement for interventional procedures, whereas VX1 focuses on electrogram analysis for guiding ablation.

Choose AngioWaveNet if…

Choose AngioWaveNet if your primary need is to enhance the clarity and detail of fluoroscopic angiograms for improved vessel visualization across various cardiac catheterization and interventional radiology procedures. This tool is ideal for improving the visibility of blood vessels, vascular structures, and anatomical features, integrating seamlessly with existing cath lab workflows and being compatible with any fluoroscopic angiography system.

View AngioWaveNet →

Choose VX1 if…

Choose VX1 if you are an electrophysiologist seeking real-time AI guidance during atrial fibrillation and atrial tachycardia ablation procedures. This software is specifically designed to assist in the real-time identification of dispersed electrograms, aiming to reduce inter-operator variability and standardize outcomes in complex electrophysiology lab interventions.

View VX1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AngioWaveNet	VX1
Pricing	Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available.	Contact for pricing
Deployment	Cloud-based or on-premise/servers	Software integrated with existing electrophysiology (EP) lab mapping and recording systems.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet emphasizes minimal training, intuitive design, and seamless integration as a post-processing tool that doesn't delay live procedures, allowing clinicians to review enhanced images side-by-side with originals. This approach likely offers a smoother adoption and less disruption to existing workflows compared to real-time procedural guidance.

Clinical Value

VX1

VX1 provides real-time AI-guided assistance during complex atrial fibrillation ablation procedures, aiming to standardize outcomes and reduce inter-operator variability. Initial clinical studies have shown promising results, with high rates of freedom from AF after VX1-guided ablation, directly impacting patient outcomes in a challenging condition.

Pricing & Value

AngioWaveNet

AngioWaveNet offers more transparent pricing models, including annual licensing or subscription-based access tailored to cath lab volume and hospital needs, with custom packages available. This provides greater flexibility and clarity for potential buyers to assess value compared to VX1's 'contact for pricing' approach.

Enterprise Readiness

AngioWaveNet

AngioWaveNet explicitly states HIPAA compliance and offers flexible deployment options (cloud or on-premise), along with vendor-agnostic compatibility and DICOM endpoint functionality. This comprehensive approach to data security, integration, and deployment makes it highly ready for enterprise adoption.

Innovation

VX1

VX1 demonstrates a higher degree of innovation by providing real-time, AI-guided decision support during complex atrial fibrillation ablation procedures, analyzing 3D anatomical and electrical maps of the heart. This active, real-time guidance directly influences procedural strategy and aims to standardize outcomes, pushing the boundaries of AI in interventional cardiology.

Support & Docs

VX1

Volta Medical's VX1 product page directly offers access to a user manual and brochure, with specific versions of the user manual cited in clinical evidence. While AngioWaveNet mentions providing software documentation to the FDA and offers onboarding, the public accessibility and specificity of support resources appear more robust for VX1.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AngioWaveNet	VX1
Name	AngioWaveNet	VX1
Company	Angiowave Imaging	Volta Medical
Primary Purpose	Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories.	Assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Specialties	Cardiology, Interventional Radiology, Vascular Surgery	Cardiology
Key Feature	AI-powered Spatiotemporal Enhancement Processing (STEPu2122) for improved vessel visualization.	AI-guided real-time identification of dispersed electrograms (EGMs).
Compatibility/Integration	Compatible with any fluoroscopic angiography system (vendor-agnostic); Functions as a DICOM endpoint.	Compatible with most EP recording, 3D navigation systems, and mapping catheters.

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and VX1.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and target specialties for each AI tool?

AngioWaveNet is designed to enhance fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, benefiting cardiology, interventional radiology, and vascular surgery. In contrast, VX1 assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures, specifically targeting cardiology (electrophysiology).

How do AngioWaveNet and VX1 integrate with existing lab equipment and workflows?

AngioWaveNet integrates with existing Cath lab workflows, functioning as a DICOM endpoint and being compatible with any fluoroscopic angiography system, regardless of vendor. VX1 is software integrated with existing electrophysiology (EP) lab mapping and recording systems, compatible with most EP recording, 3D navigation systems, and mapping catheters.

What specific AI capabilities does each tool offer to assist physicians?

AngioWaveNet utilizes AI-powered Spatiotemporal Enhancement Processing (STEPu2122) to improve the visibility of blood vessels, vascular structures, and anatomical features in fluoroscopic angiograms. VX1 provides AI-guided real-time identification of dispersed electrograms (EGMs) and analyzes 3D anatomical and electrical maps of human atria during ablation procedures, also offering cycle length estimation.

How do the pricing models differ between AngioWaveNet and VX1?

AngioWaveNet offers transparent pricing options, including annual software licensing or subscription-based access, which can be tailored to cath lab volume and hospital needs, with custom packages available. For VX1, pricing information is not explicitly stated in the provided details, and interested parties are advised to contact the company for pricing.